Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin sodium fluoride PET/CT study in osteopenia
NL-OMON38994Withdrawn
- Sponsor
- University Medical Center Utrecht
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of simvastatin in osteopenia and arterial calcification, sponsored by University Medical Center Utrecht. Primary endpoint: Absolute change in vertebral fluorine-18 metabolism. Planned start Jan 2014; status: withdrawn.
02
Drugs
simvastatin
03
Conditions
osteopeniaarterial calcification
Beyond the preview
Go deeper on NL-OMON38994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38994.